Phospho-p53 (T18) Polyclonal Antibody, 100 µg, (ATB-P0212)
$238.00
- Description
- Size Guide
- Reviews (0)
Description
Background:
Acts as a tumor suppressor in many tumor types; induces growth arrest or apoptosis depending on the physiological circumstances and cell type. Involved in cell cycle regulation as a trans-activator that acts to negatively regulate cell division by controlling a set of genes required for this process. One of the activated genes is an inhibitor of cyclin-dependent kinases. Apoptosis induction seems to be mediated either by stimulation of BAX and FAS antigen expression, or by repression of Bcl-2 expression. In cooperation with mitochondrial PPIF is involved in activating oxidative stress-induced necrosis; the function is largely independent of transcription. Induces the transcription of long intergenic non-coding RNA p21 (lincRNA-p21) and lincRNA-Mkln1. LincRNA-p21 participates in TP53-dependent transcriptional repression leading to apoptosis and seem to have to effect on cell-cycle regulation. Implicated in Notch signaling cross-over. Prevents CDK7 kinase activity when associated to CAK complex in response to DNA damage, thus stopping cell cycle progression. Isoform 2 enhances the transactivation activity of isoform 1 from some but not all TP53-inducible promoters. Isoform 4 suppresses transactivation activity and impairs growth suppression mediated by isoform 1. Isoform 7 inhibits isoform 1-mediated apoptosis.
Product datasheet:
Overview | |
| Product Description | |
| Species Reactivities | Human,Mouse,Rat |
| Immunogen | Synthesized peptide derived from human p53 around the phosphorylation site of T18. |
Properties | |
| Form | Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide. |
| Storage Instructions | -20°C/1 year |
| Clonality | Polyclonal |
References:
- Human p53 cellular tumor antigen: cDNA sequence and expression in COS cells.
Zakut-Houri R., Bienz-Tadmor B., Givol D., Oren M.
EMBO J. 4:1251-1255(1985) [PubMed] [Europe PMC] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1). - Characterization of the human p53 gene.
Lamb P., Crawford L.
Mol. Cell. Biol. 6:1379-1385(1986) [PubMed] [Europe PMC] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ISOFORM 1), VARIANT GLY-76. - Molecular cloning and in vitro expression of a cDNA clone for human cellular tumor antigen p53.
Harlow E., Williamson N.M., Ralston R., Helfman D.M., Adams T.E.
Mol. Cell. Biol. 5:1601-1610(1985) [PubMed] [Europe PMC] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1). - Molecular basis for heterogeneity of the human p53 protein.
Harris N., Brill E., Shohat O., Prokocimer M., Wolf D., Arai N., Rotter V.
Mol. Cell. Biol. 6:4650-4656(1986) [PubMed] [Europe PMC] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1). - A variation in the structure of the protein-coding region of the human p53 gene.
Buchman V.L., Chumakov P.M., Ninkina N.N., Samarina O.P., Georgiev G.P.
Gene 70:245-252(1988) [PubMed] [Europe PMC] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA]. - p53 is frequently mutated in Burkitt’s lymphoma cell lines.
Farrell P.J., Allan G., Shanahan F., Vousden K.H., Crook T.
EMBO J. 10:2879-2887(1991) [PubMed] [Europe PMC] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), VARIANTS SPORADIC CANCERS. - Isolation of two cell lines from a human malignant glioma specimen differing in sensitivity to radiation and chemotherapeutic drugs.
Allalunis-Turner M.J., Barron G.M., Day R.S. III, Dobler K.D., Mirzayans R.
Radiat. Res. 134:349-354(1993) [PubMed] [Europe PMC] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA], VARIANT LYS-286. - Hyaluronidase induction of a WW domain-containing oxidoreductase that enhances tumor necrosis factor cytotoxicity.
Chang N.-S., Pratt N., Heath J., Schultz L., Sleve D., Carey G.B., Zevotek N.
J. Biol. Chem. 276:3361-3370(2001) [PubMed] [Europe PMC] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), INTERACTION WITH WWOX. - p53 isoforms can regulate p53 transcriptional activity.
Bourdon J.C., Fernandes K., Murray-Zmijewski F., Liu G., Diot A., Xirodimas D.P., Saville M.K., Lane D.P.
Genes Dev. 19:2122-2137(2005) [PubMed] [Europe PMC] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1; 2; 3; 7; 8 AND 9), SUBCELLULAR LOCATION, TISSUE SPECIFICITY, ALTERNATIVE PROMOTER USAGE, ALTERNATIVE SPLICING, INDUCTION, VARIANT ARG-72. Tissue: Colon. - Chumakov P.M., Almazov V.P., Jenkins J.R.
Submitted (JUN-1991) to the EMBL/GenBank/DDBJ databasesCited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA].


| size | chest(in.) | waist(in.) | hips(in.) |
|---|---|---|---|
| XS | 34-36 | 27-29 | 34.5-36.5 |
| S | 36-38 | 29-31 | 36.5-38.5 |
| M | 38-40 | 31-33 | 38.5-40.5 |
| L | 40-42 | 33-36 | 40.5-43.5 |
| XL | 42-45 | 36-40 | 43.5-47.5 |
| XXL | 45-48 | 40-44 | 47.5-51.5 |




Reviews
There are no reviews yet.